← Back to catalogue

artus® CMV RGQ MDx Kit

FDA UDI

Class II (US FDA UDI)

by Qiagen, Inc.

Identity

Trade Name
artus® CMV RGQ MDx Kit FDA UDI
Generic Name
Cytomegalovirus (CMV) nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Model / Reference
1 FDA UDI

Identifiers

Catalog Number
4503245 FDA UDI
Primary DI / UDI-DI
04053228002086 FDA UDI
PMA Number
P130027 FDA UDI
FDA Product Code
PAB FDA UDI
GMDN Term
Cytomegalovirus (CMV) nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3180 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cytomegalovirus (CMV) nucleic acid IVD, kit, nucleic acid technique (NAT)

artus® CMV RGQ MDx Kit by Qiagen, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cytomegalovirus (CMV) nucleic acid IVD, kit, nucleic acid technique (NAT).

Cleared under the same submission

P130027 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Qiagen, Inc.

Sources (1)

  • FDA UDI 200eee08-c7a9-4a21-a8e7-e0cb2c8ea93f 34 fields · synced Jun 1, 2026